Skip to main content
. Author manuscript; available in PMC: 2015 Jun 15.
Published in final edited form as: Clin Cancer Res. 2014 Apr 25;20(12):3211–3221. doi: 10.1158/1078-0432.CCR-13-3116

Figure 5. Co-expression of PLK1 and PIM1 in human prostate tumors.

Figure 5

A, Representative images showing high expression levels of PIM1 and PLK1 as well as co-localization in human prostate tumors. Normal prostate glands show low expression levels of both PIM1 and PLK1.

B, Venn diagram showing a significant percentage of human prostate tumor samples co-expressing PIM1 and PLK1. N = 162.

C, Co-expression of PLK1 and PIM1 was significantly correlated to higher Gleason scores (P = 0.00012, Chi-square). Human microarray tissues were immunostained with both PIM1 and PLK1 antibodies.